Dilantin Injection Can Cause Purple Glove Syndrome
Purple Glove Syndrome means a dangerous skin disease where one’s extremities swell and become discoloured and painful. In a recently released report Food & Drug Administration (FDA) is investigating cases where use of Dilantin has lead to this potentially dangerous disease.
Purple Glove Syndrome starts as a pale blue or dark purple discoloration which appears around the intravenous insertion site 2 to 12 hours after the administration of the drug. Progression occurs during the next 12 to 16 hours as developing edema and continued discoloration spread around all sides of the affected limb. If a patient is fortunate, the discoloration and edema will gradually fade, and the affected limb will heal within 2 to 4 weeks.